Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 430,874 | 466,544 | 530,194 | 371,884 | 383,122 |
| Receivables | 26,752 | 30,218 | 15,896 | 2,079 | N/A |
| Inventories | 11,838 | 11,122 | 8,008 | 7,718 | N/A |
| Other current assets | 18,246 | 17,298 | 14,310 | 12,751 | 10,120 |
| TOTAL | $487,710 | $525,182 | $568,408 | $394,432 | $393,242 |
| Non-Current Assets | |||||
| PPE Net | 3,938 | 4,066 | 4,022 | 3,261 | 2,391 |
| Investments And Advances | 38,734 | 41,236 | 44,002 | 46,212 | 47,381 |
| Intangibles | 13,851 | 13,582 | 13,316 | 12,010 | 10,147 |
| Other Non-Current Assets | 37,653 | 33,906 | 8,231 | 8,471 | 8,544 |
| TOTAL | $94,176 | $92,790 | $69,571 | $69,954 | $68,463 |
| Total Assets | $581,886 | $617,972 | $637,979 | $464,386 | $461,705 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,549 | 6,575 | 6,575 | 6,193 | 3,594 |
| Accounts payable and accrued liabilities | 16,453 | 12,080 | 12,028 | 14,631 | 11,462 |
| Other current liabilities | 40,411 | 50,497 | 39,685 | 29,450 | 25,272 |
| TOTAL | $70,774 | $73,935 | $59,300 | $51,499 | $41,398 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 348,445 | 377,949 | 391,371 | 168,969 | 122,339 |
| TOTAL | $348,445 | $377,949 | $391,371 | $168,969 | $122,339 |
| Total Liabilities | $419,219 | $451,884 | $450,671 | $220,468 | $163,737 |
| Shareholders' Equity | |||||
| Common Shares | 6,445 | 6,445 | 6,445 | 6,445 | 6,314 |
| Retained earnings | -941,546 | -924,885 | -890,504 | -818,955 | -746,386 |
| Other shareholders' equity | 115,950 | 102,701 | 89,797 | 75,138 | 56,981 |
| TOTAL | $162,667 | $166,088 | $187,308 | $243,918 | $297,968 |
| Total Liabilities And Equity | $581,886 | $617,972 | $637,979 | $464,386 | $461,705 |